Navigation Links
Retrospective Analysis Explores LYSTEDA®'s Ability to Reduce Sleep Interruptions in Women With Cyclic Heavy Menstrual Bleeding
Date:5/4/2011

LYSTEDA in women who are taking more than the approved dose of a hormonal contraceptive.

Concomitant use of LYSTEDA with Factor IX complex concentrates, anti-inhibitor coagulant concentrates or all-trans retinoic acid (oral tretinoin) may increase risk of thrombosis.  Visual or ocular adverse effects may occur with LYSTEDA.  Immediately discontinue use if visual or ocular symptoms occur.  In case of severe allergic reaction, discontinue LYSTEDA and seek immediate medical attention.  Cerebral edema and cerebral infarction may be caused by use of LYSTEDA in women with subarachnoid hemorrhage.  Ligneous conjunctivitis has been reported in patients taking tranexamic acid.

The most common adverse reactions in clinical trials (≥5%, and more frequent in LYSTEDA subjects compared to placebo subjects) were: headache, sinus and nasal symptoms, back pain, abdominal pain, musculoskeletal pain, joint pain, muscle cramps, migraine, anemia, and fatigue.  

About Ferring Pharmaceuticals Inc.

Ferring Pharmaceuticals Inc. is a subsidiary of Ferring Pharmaceuticals, a privately owned, international pharmaceutical company.  Ferring Pharmaceuticals offers a line of products in the U.S. market.  They include: LYSTEDA tablets, BRAVELLE® (urofollitropin for injection, purified), MENOPUR® (menotropins for injection, USP) and REPRONEX® (menotropins for injection, USP), NOVAREL® (chorionic gonadotropin for injection, USP), ENDOMETRIN® (progesterone) Vaginal Insert, 100 mg, FIRMAGON® (degarelix for injection), PROSED® DS (methenamine, phenyl salicylate, methylene blue, benzoic acid, hyoscyamine sulfate), DESMOPRESSIN, and EUFLEXXA® (1% sodium hyaluronate).

Ferring Pharmaceuticals specializes in the research, development and commercialization of compounds in general and pediatric endocrinology, urology, orthopaedics, gastroenterology, obstetrics/gynecology, and infert
'/>"/>

SOURCE Ferring Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry
2. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
3. Reportlinker Adds Triple Analysis: Leukemia, Lymphoma and Pancreatic Cancer
4. Reportlinker Adds Triple Analysis: Leukemia, Prostate Cancer and Apoptosis
5. Reportlinker Adds Triple Analysis: Colorectal Cancer, Leukemia and Apoptosis
6. Reportlinker Adds Triple Analysis: Leukemia, Pancreatic Cancer and Prostate Cancer
7. Reportlinker Adds Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, April 2011
8. Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
9. Reportlinker Adds Medical Equipment Annual Deals Analysis 2011
10. Anthera Pharmaceuticals Successfully Completes Interim Biomarker Analysis of VISTA-16 Study and Third Safety Review of Varespladib Methyl
11. Pharmatek Granted Approval by the DEA for Analysis of All Controlled Substances
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... Ill. , Aug. 3, 2015  Landauer, Inc. ... and environmental radiation measurement and monitoring, outsourced medical physics ... it will release financial results for the fiscal third ... 10, 2015. The Company will also ... 11, 2015 at 9:00 a.m. Central Time (10:00 a.m. ...
(Date:8/3/2015)... Aug. 3, 2015 AcelRx Pharmaceuticals, Inc. (Nasdaq: ... the development and commercialization of innovative therapies for the ... and reported financial results for the three and six ... include: , On July 23, 2015, the Committee ... positive opinion for Zalviso™ for the management of acute ...
(Date:8/3/2015)... , Aug. 3, 2015  LEO Pharma supports ... Administration (FDA) to include psoriasis as one of eight ... Development Initiative i .  Psoriasis is an autoimmune disease ... subsequent comorbidities, affecting 7.5 million people in the US ... Pharma,s ongoing commitment to supporting patients living with psoriasis, ...
Breaking Medicine Technology:Landauer, Inc. Announces Date And Time For Announcement Of Fiscal Third Quarter 2015 Results And Conference Call 2AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 2AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 3AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 4AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 5AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 6AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 7AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 8AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 9AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 10LEO Pharma Supports the FDA's Selection of Psoriasis as a Priority Disease 2LEO Pharma Supports the FDA's Selection of Psoriasis as a Priority Disease 3
...  In Pennsylvania,s latest effort to strengthen highway safety, 13 ... been trained as drug recognition experts, State Police Commissioner ... experts, known as DREs, are trained to recognize signs ... of drugs other than, or in addition to, alcohol. ...
... 7, 2012  Ventana Medical Systems, Inc. (Ventana), a ... from the U.S. Food and Drug Administration (FDA) ... analysis application using the VENTANA iScan Coreo Au ... only company offering an FDA-cleared p53 image analysis ...
Cached Medicine Technology:Pennsylvania Puts Additional 20 Drug Recognition Experts on the Road 2Pennsylvania Puts Additional 20 Drug Recognition Experts on the Road 3Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications 2Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications 3
(Date:8/4/2015)... ... August 04, 2015 , ... They say a picture is worth a ... pictures and medical art can be essential. StayWell, a health solutions company, announced today ... Education solutions have been used by physicians and other health care providers for more ...
(Date:8/4/2015)... San Francisco, Calif. (PRWEB) , ... August 04, ... ... services to corporations, law firms and government entities, today announced that John Munro, ... leadership team as Vice President of Managed Services Operations. , “I am thrilled ...
(Date:8/4/2015)... ... August 04, 2015 , ... Patients are ... offered by the world renowned Beverly Hills facelift surgeon , Dr. Paul ... surgery techniques helps individuals to achieve an outer appearance that meets their personal ...
(Date:8/4/2015)... , ... August 04, 2015 , ... T.E.N., an information ... vendor participating in The ISE® Lions’ Den and Jungle Lounge 2015, which will be ... Las Vegas. , During the event, eight emerging security vendors, known as “Gazelles,” will ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... look at unique artistic expressions from a diverse group of exceptionally talented female ... Beautiful Music & Art Festival on September 25-27, 2015 in Downtown Las Vegas. ...
Breaking Medicine News(10 mins):Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 2Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 3Health News:John Munro Joins eDiscovery Leader Discovia as Vice President of Managed Services Operations 2Health News:John Munro Joins eDiscovery Leader Discovia as Vice President of Managed Services Operations 3Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 2Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 3Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 4Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 2Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 3Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 4
... new report shows that a non-ambulatory (unable to walk ... was able to restore basic walking function after intensive ... Therapy (May 2008), the scientific journal of the American ... training in a 4 year-old-boy, who had no ...
... Berlin ... from 22 to 24 September, BERLIN, June 4 How can ... world will address this question at the 4th International,Forum on Disability Management ... to 24 September 2008. The IFDM will be hosted by,the German Social ...
... and how to use,an Automated External Defibrillator (AED) can ... from Sudden Cardiac Arrest or other,medical emergency. During this ... the American Red Cross encourages everyone,to learn these important ... want the public to know that everyone has the ...
... inflammation and subsequent destruction of the tissues supporting the ... solution to this problem. At the Academic Centre for ... the periodontal ligament by use of tissue engineering. The ... be promising for regenerating periodontal ligament and may also ...
... Eye Research Australia/ Access Economics report shows the cost of ... , ,Tunnel Vision: the Economic Impact of Primary Open ... 2005 and costs are expected to climb to $4.3 billion ... current practices. , Glaucoma damages the optic nerve, connecting the ...
... improved results , , WEDNESDAY, June 4 (HealthDay News) -- ... even if they eventually stop attending meetings, says a ... centers in California. , The teens, with an ... at the centers, which were focused on abstinence and ...
Cached Medicine News:Health News:New report shows locomotor training restores walking function in child with spinal cord injury 2Health News:Retaining Employees' Capacity For Work Following Sickness 2Health News:American Red Cross of Southeastern Michigan Celebrates National CPR/AED Awareness Week 2Health News:Saving teeth by using periodontal ligament regeneration 2Health News:Glaucoma report points to increased costs 2Health News:Alcohol, Drug Counseling Benefits Teens, Too 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: